NeuroVive Pharmaceutical AB — Form D

NeuroVive Pharmaceutical AB of 81 LUND, V7, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-27. The offering totals $25.0M, of which $7.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2015-05-27
• Form: D
• Accession: 0001144204-15-033524
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $25.0M
• Amount sold: $7.5M
• Remaining: $17.5M
• Investors: 11
• Date of first sale: 2015-05-08
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-240553

Issuer

• Name: NeuroVive Pharmaceutical AB
• CIK: 0001643349
• Entity type: Corporation
• Jurisdiction: SWEDEN
• Address: MEDICON VILLAGE SE-223, 81 LUND, V7, None
• Phone: +46-46-275 6220

Officers, directors & promoters (13)

More

• CIK 1643349 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search